The Inflammatory Bowel Disease (IBD) treatment market has witnessed significant growth, with a valuation of USD 19.6 billion in 2023. This growth trajectory is expected to continue, with the market projected to expand at a CAGR of 5.71% from 2024 to 2032, reaching a value of USD 32.3 billion by 2032. The driving forces behind […]
